Salidroside protects PC-12 cells against amyloid β-induced apoptosis by activation of the ERK1/2 and AKT signaling pathways

Liao,Zheng‑Luan; Su,Heng; Tan,Yun‑Fei; Qiu,Ya‑Ju; Zhu,Jun‑Peng; Chen,Yan; Lin,Si‑Si; Wu,Ming‑Hao; Mao,Yan‑Ping; Hu,Jiao‑Jiao; Yu,En‑Yan

doi:10.3892/ijmm.2019.4088

Salidroside protects PC-12 cells against amyloid β-induced apoptosis by activation of the ERK1/2 and AKT signaling pathways

Authors:
- Zheng‑Luan Liao
- Heng Su
- Yun‑Fei Tan
- Ya‑Ju Qiu
- Jun‑Peng Zhu
- Yan Chen
- Si‑Si Lin
- Ming‑Hao Wu
- Yan‑Ping Mao
- Jiao‑Jiao Hu
- En‑Yan Yu
View Affiliations

Affiliations: Department of Psychiatry, Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang 310014, P.R. China, Psychiatry and Mental Health, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, P.R. China, Psychiatry and Mental Health, Bengbu Medical College, Bengbu, Anhui 233030, P.R. China
Published online on: February 1, 2019 https://doi.org/10.3892/ijmm.2019.4088
Pages: 1769-1777
Copyright: © Liao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Alzheimer's disease (AD) is one of the most frequent diseases in elderly people and causes high mortality. Its incidence is increasing annually and no effective therapeutic treatment currently exists. In the present study, salidroside, a major active ingredient of Rhodiola rosea, was able to protect PC‑12 cells from the toxicity and apoptosis induced by AD inducer amyloid (A)β1‑42. Salidroside significantly protected PC‑12 cells by inhibiting Aβ1‑42‑induced cytotoxicity and mitochondria‑mediated endogenous caspase apoptotic pathways. Mechanistic studies demonstrated that salidroside significantly activated the extracellular signal regulated kinase (ERK)1/2 and protein kinase B (AKT) signaling pathways. This observation was further confirmed using the ERK1/2 inhibitor PD98059 and the AKT inhibitor LY294002, which demonstrated that salidroside promoted PC‑12 cell survival and proliferation by activating the ERK1/2 and AKT signaling pathways. Salidroside is a therapeutic candidate for the treatment of AD and provides a basis for further drug development.

View Figures

View References

1	Jarrett JT and Lansbury PT Jr: Seeding ‘one-dimensional crystallization’ of amyloid: A pathogenic mechanism in Alzheimer’s disease and scrapie? Cell. 73:1055–1058. 1993. View Article : Google Scholar : PubMed/NCBI
2	Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Bäckman L, Albert M, Almkvist O, et al: Mild cognitive impairment-beyond controversies, towards a consensus: Report of the international working group on mild cognitive impairment. J Intern Med. 256:240–246. 2004. View Article : Google Scholar : PubMed/NCBI
3	Coyle JT, Price DL and DeLong MR: Alzheimer’s disease: A disorder of cortical cholinergic innervation. Science. 219:1184–1190. 1983. View Article : Google Scholar : PubMed/NCBI
4	Alzheimer’s A: 2011 Alzheimer’s disease facts and figures. W V Med J. 107:82–83. 2011.
5	Colucci L, Bosco M, Fasanaro AM, Gaeta GL, Ricci G and Amenta F: Alzheimer’s disease costs: What we know and what we should take into account. J Alzheimers Dis. 42:1311–1324. 2014. View Article : Google Scholar
6	Ittner LM and Gotz J: Amyloid-β and tau - a toxic pas de deux in Alzheimer’s disease. Nat Rev Neurosci. 12:65–72. 2011. View Article : Google Scholar : PubMed/NCBI
7	Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A, et al: Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer’s disease. Nat Genet. 41:1088–1093. 2009. View Article : Google Scholar : PubMed/NCBI
8	Bertram L and Tanzi RE: Alzheimer disease: New light on an old CLU. Nat Rev Neurol. 6:11–13. 2010. View Article : Google Scholar : PubMed/NCBI
9	Selkoe DJ: The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer’s disease. Trends Cell Biol. 8:447–453. 1998. View Article : Google Scholar : PubMed/NCBI
10	Love S and Kehoe PG: Clearance of Abeta from the brain in Alzheimer’s disease. Foreword. Brain Pathol. 18:2392008. View Article : Google Scholar
11	Akwa Y, Allain H, Bentue-Ferrer D, Berr C, Bordet R, Geerts H, Nieoullon A, Onteniente B and Vercelletto M: Neuroprotection and neurodegenerative diseases: From biology to clinical practice. Alzheimer Dis Assoc Disord. 19:226–239. 2005. View Article : Google Scholar : PubMed/NCBI
12	Yao J, Irwin RW, Zhao L, Nilsen J, Hamilton RT and Brinton RD: Mitochondrial bioenergetic deficit precedes Alzheimer’s pathology in female mouse model of Alzheimer’s disease. Proc Natl Acad Sci USA. 106:14670–14675. 2009. View Article : Google Scholar
13	Zeng Z, Xu J and Zheng W: Artemisinin protects PC12 cells against β-amyloid-induced apoptosis through activation of the ERK1/2 signaling pathway. Redox Biol. 12:625–633. 2017. View Article : Google Scholar : PubMed/NCBI
14	Godyn J, Jonczyk J, Panek D and Malawska B: Therapeutic strategies for Alzheimer’s disease in clinical trials. Pharmacol Rep. 68:127–138. 2016. View Article : Google Scholar
15	Cummings JL, Morstorf T and Zhong K: Alzheimer’s disease drug-development pipeline: Few candidates, frequent failures. Alzheimers Res Ther. 6:372014. View Article : Google Scholar
16	Selkoe DJ and Hardy J: The amyloid hypothesis of Alzheimer’s disease at 25 years. EMBO Mol Med. 8:595–608. 2016. View Article : Google Scholar : PubMed/NCBI
17	Abidov M, Crendal F, Grachev S, Seifulla R and Ziegenfuss T: Effect of extracts from Rhodiola rosea and Rhodiola crenulata (Crassulaceae) roots on ATP content in mitochondria of skeletal muscles. Bull Exp Biol Med. 136:585–587. 2003. View Article : Google Scholar
18	Zhang J, Zhen YF, Pu-Bu-Ci-Ren, Song LG, Kong WN, Shao TM, Li X and Chai XQ: Salidroside attenuates beta amyloid-induced cognitive deficits via modulating oxidative stress and inflammatory mediators in rat hippocampus. Behav Brain Res. 244:70–81. 2013. View Article : Google Scholar : PubMed/NCBI
19	Liu Z, Li X, Simoneau AR, Jafari M and Zi X: Rhodiola rosea extracts and salidroside decrease the growth of bladder cancer cell lines via inhibition of the mTOR pathway and induction of autophagy. Mol Carcinog. 51:257–267. 2012. View Article : Google Scholar
20	Zhang L, Yu H, Zhao X, Lin X, Tan C, Cao G and Wang Z: Neuroprotective effects of salidroside against beta-amyloid-induced oxidative stress in SH-SY5Y human neuroblastoma cells. Neurochem Int. 57:547–555. 2010. View Article : Google Scholar : PubMed/NCBI
21	Hu M, Waring JF, Gopalakrishnan M and Li J: Role of GSK-3beta activation and alpha7 nAChRs in Abeta(1–42)-induced tau phosphorylation in PC12 cells. J Neurochem. 106:1371–1377. 2008. View Article : Google Scholar : PubMed/NCBI
22	Mahbub AA, Le Maitre CL, Haywood-Small SL, McDougall GJ, Cross NA and Jordan-Mahy N: Differential effects of poly-phenols on proliferation and apoptosis in human myeloid and lymphoid leukemia cell lines. Anticancer Agents Med Chem. 13:1601–1613. 2013. View Article : Google Scholar : PubMed/NCBI
23	Simon HU, Haj-Yehia A and Levi-Schaffer F: Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis. 5:415–418. 2000. View Article : Google Scholar
24	Ly JD, Grubb DR and Lawen A: The mitochondrial membrane potential (deltapsi(m)) in apoptosis. An update Apoptosis. 8:115–128. 2003. View Article : Google Scholar
25	Green DR and Reed JC: Mitochondria and apoptosis. Science. 281:1309–1312. 1998. View Article : Google Scholar : PubMed/NCBI
26	Bufill E, Bartes A, Moral A, Casadevall T, Codinachs M, Zapater E, Carles Rovira J, Roura P, Oliva R and Blesa R: Genetic and environmental factors that may influence in the senile form of Alzheimer’s disease: Nested case control studies. Neurologia. 24:108–112. 2009.In Spanish. PubMed/NCBI
27	Di Paolo G and Kim TW: Linking lipids to Alzheimer’s disease: Cholesterol and beyond. Nat Rev Neurosci. 12:284–296. 2011. View Article : Google Scholar : PubMed/NCBI
28	Butterfield DA and Boyd-Kimball D: Oxidative stress, amyloid-β peptide, and altered key molecular pathways in the pathogenesis and progression of Alzheimer’s disease. J Alzheimers Dis. 62:1345–1367. 2018. View Article : Google Scholar :
29	Knezevic D and Mizrahi R: Molecular imaging of neuroinflammation in Alzheimer’s disease and mild cognitive impairment. Prog Neuropsychopharmacol Biol Psychiatry. 80:123–131. 2018. View Article : Google Scholar
30	Ma YG, Wang JW, Zhang YB, Wang BF, Dai ZJ, Xie MJ and Kang HF: Salidroside improved cerebrovascular vasodilation in streptozotocin-induced diabetic rats through restoring the function of BKCa channel in smooth muscle cells. Cell Tissue Res. 370:365–377. 2017. View Article : Google Scholar : PubMed/NCBI
31	Liu X, Bai Y, Liang L, Feng J and Deng F: Salidroside improves pulmonary fibrosis by down-regulation of cathepsin B and NF-κBp65 in rats. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 42:128–133. 2017.In Chinese. PubMed/NCBI
32	Richter L, Munter LM, Ness J, Hildebrand PW, Dasari M, Unterreitmeier S, Bulic B, Beyermann M, Gust R, Reif B, et al: Amyloid beta 42 peptide (Abeta42)-lowering compounds directly bind to Aβ and interfere with amyloid precursor protein (APP) transmembrane dimerization. Proc Natl Acad Sci USA. 107:14597–14602. 2010. View Article : Google Scholar
33	Postu PA, Noumedem JAK, Cioanca O, Hancianu M, Mihasan M, Ciorpac M, Gorgan DL, Petre BA and Hritcu L: Lactuca capensis reverses memory deficits in Aβ1–42-induced an animal model of Alzheimer’s disease. J Cell Mol Med. 22:111–122. 2018. View Article : Google Scholar
34	Lu Z and Xu S: ERK1/2 MAP kinases in cell survival and apoptosis. IUBMB Life. 58:621–631. 2006. View Article : Google Scholar : PubMed/NCBI
35	Franke TF, Hornik CP, Segev L, Shostak GA and Sugimoto C: PI3K/Akt and apoptosis: Size matters. Oncogene. 22:8983–8998. 2003. View Article : Google Scholar : PubMed/NCBI
36	Imai Y, Yamagishi H, Ono Y and Ueda Y: Versatile inhibitory effects of the flavonoid-derived PI3K/Akt inhibitor, LY294002, on ATP-binding cassette transporters that characterize stem cells. Clin Transl Med. 1:242012. View Article : Google Scholar
37	Zhu C, Qi X, Chen Y, Sun B, Dai Y and Gu Y: PI3K/Akt and MAPK/ERK1/2 signaling pathways are involved in IGF-1-induced VEGF-C upregulation in breast cancer. J Cancer Res Clin Oncol. 137:1587–1594. 2011. View Article : Google Scholar : PubMed/NCBI